Resources
2 Results (showing 1 - 2)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 12/12/2023 (updated 3/28/2024)
Given the epidemic of increased maternal mortality and morbidity in the U.S., there is growing sentiment on how to mitigate preventable causes, including that of addressing substance use disorder (SUD). This webinar provided information on the complications of SUD in pregnancy, along with methods for effective intervention and management for clinicians and collaborators.
Posted 10/23/2023 (updated 3/27/2024)
The Reagan-Udall Foundation partnered with the Food and Drug Administration (FDA) for the "Mitigating Risks from Human Xylazine Exposure" virtual and in-person webinar that occurred early October 2023. This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research that directly supports the mitigation and reduction of risks associated with human exposure to xylazine. The meeting materials, recordings, and slides are now available for viewing.